(19)
(11) EP 4 815 984 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24828223.8

(22) Date of filing: 26.11.2024
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
A61K 31/47(2006.01)
C07K 16/28(2006.01)
A61K 31/00(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/505; A61K 39/3955; A61K 2039/545; C07K 2317/76; C07K 16/2839; A61K 45/06; A61K 31/5377; A61K 2300/00
(86) International application number:
PCT/US2024/057400
(87) International publication number:
WO 2025/117506 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 US 202363604090 P

(71) Applicant: Gilead Sciences Inc.
Foster City, California 94404 (US)

(72) Inventors:
  • CLARKE, Astrid S.
    San Marcos, California 92078 (US)
  • KUO, Dahtsing
    Foster City, California 94404 (US)
  • LOPEZ, David A.
    Foster City, California 94404 (US)
  • ROEDDER, Silke
    Menlo Park, California 94025 (US)
  • YI, Tangsheng
    Foster City, California 94404 (US)
  • ZHOU, Jin
    Foster City, California 94404 (US)
  • GENOVESE, Mark C.
    Sunnyvale, California 94087 (US)

(74) Representative: Schnappauf, Georg 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) THERAPIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE